Can Well-Managed Diabetes Still Lead to Kidney Failure?
This research paper investigates the relationship between diabetes management and the risk of developing kidney failure. While conventional wisdom holds that controlling blood sugar levels reduces the likelihood of chronic kidney disease, accumulating evidence suggests that even well-managed diabetes can still progress to kidney failure. The paper examines contributing factors such as high blood pressure, obesity, genetics, and ethnic background, and reviews existing literature on the role of glycemic control and microalbuminuria detection. It outlines a comparative quantitative research methodology using historical patient records and concludes by underscoring the need for improved clinical protocols to reduce the incidence and financial burden of diabetic kidney disease in the United States.
- Introduction: Diabetes as a leading cause of kidney failure
- Rationale and Significance: Risk factors, costs, and study justification
- Purpose, Hypothesis, and Research Questions: Study goals, hypothesis, and four research questions
- Literature Review: Evidence on glycemic control and kidney disease progression
- Methodology: Comparative quantitative design using patient records
- Conclusion: Study implications for diabetes and kidney disease prevention
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper clearly challenges a common assumption — that controlling diabetes guarantees protection against kidney failure — and grounds that challenge in cited epidemiological data, giving the argument immediate practical relevance.
- The research questions are well-structured and directly tied to the central hypothesis, providing a clear roadmap for the proposed study.
- The literature review synthesizes conflicting findings honestly, acknowledging that current evidence does not fully resolve the question, which strengthens the justification for the proposed research.
Key academic technique demonstrated
The paper demonstrates effective use of a research proposal framework: it moves from problem statement and rationale through hypothesis formation, literature review, and methodology in a logical sequence. The explicit articulation of both a primary hypothesis and a null hypothesis reflects sound scientific reasoning and is a strong model for undergraduate research writing.
Structure breakdown
The paper opens with an introduction establishing the scope and scale of the problem, followed by sections on rationale, significance, purpose, and hypothesis. A focused literature review synthesizes three key studies alongside USRDS data. A methodology section describes the comparative quantitative approach, and a brief conclusion reiterates the study's goals. The structure follows a standard research proposal format appropriate for an undergraduate health sciences course.
Introduction
Kidney failure is the final stage of chronic kidney disease, in which the body loses its ability to rid itself of waste. When the kidneys fail, dangerous levels of toxins accumulate in the body, leading to death. Nearly 100,000 people are diagnosed with kidney failure in the United States every year (USRDS, 2007). According to the same data, diabetes accounts for just under half of these new cases. Controlling diabetes is important, and doctors are correct to stress this point to their patients. However, recent data suggests that even when diabetes is controlled, it can still lead to kidney failure. Nearly 24 million people in the United States have diabetes, and nearly 180,000 are living with kidney failure that is a direct result of diabetes (USRDS, 2007). This research explores the connection between diabetes and kidney failure, with particular attention to the importance of controlling diabetes.
Rationale and Significance
Many people believe that if they have diabetes and manage it well, they are guaranteed to avoid chronic kidney disease. However, this is not always the case, particularly when several risk factors are combined — such as high blood pressure alongside diabetes. Genetics can also play a role; minorities such as African Americans, American Indians, and Hispanics have higher kidney failure rates than Caucasians (USRDS, 2007). This study is grounded in research indicating that to avoid kidney failure, diabetes must not merely be controlled but, ideally, eliminated.
Most U.S. citizens with kidney disease are eligible for some form of federally funded care. It is estimated that patients with kidney failure cost the United States nearly $32 billion annually (USRDS, 2007). The financial impact of the disease is devastating, as is the effect on individual lives and the added strain on an already pressured health care system. Heredity plays a role in kidney disease, but there are many more cases in which heredity is not a factor than cases in which it is. Kidney disease can be avoided, or its risk reduced, by taking straightforward steps such as maintaining a proper diet and exercising regularly. It has also been suggested that controlling other risk factors — such as high blood pressure — can reduce the risk of kidney failure in those with diabetes (USRDS, 2007). Reducing the incidence of kidney failure would have a significant impact not only on patients and their families, but also on the economy of the United States.
Purpose, Hypothesis, and Research Questions
The purpose of this study is two-fold. The first is to gather evidence-based information about the relationship between controlled diabetes, uncontrolled diabetes, and the likelihood of developing kidney failure. The second is to equip health care professionals with information they can use to develop protocols and patient guidance aimed at reducing the risk of kidney failure. This research will benefit both physicians and patients alike.
This research focuses on a single central hypothesis: that individuals with controlled diabetes remain at risk for the development of kidney failure. The null hypothesis states that controlled diabetes will significantly reduce the risk of developing kidney failure.
In addition to the primary hypothesis, the study addresses several research questions that provide greater insight into the issues surrounding the hypothesis:
1. How is diabetes related to kidney failure, regardless of whether it is controlled or uncontrolled?
2. Once a person has diabetes, is there anything they can do to reduce their risk of developing kidney failure?
3. Is high blood pressure more important than blood sugar levels in the development of kidney failure among people with diabetes?
4. Does controlling diabetes alone reduce the risk of developing kidney failure?
These four research questions will help build a greater understanding of the connection between diabetes and kidney failure, and will aid physicians and medical professionals in advising their patients on how to reduce their chances of developing kidney failure.
Literature Review
Diabetic kidney disease is a progressive and potentially fatal condition. The kidneys' filtration system begins to fail gradually, resulting in small amounts of protein leaking into the urine. As the disease progresses, more protein leaks into the urine and the kidneys' filtering capacity declines. As a result, the body retains high levels of waste. The disease rarely occurs within the first 10 years of diabetes, and it is usually 15 to 25 years before kidney failure occurs (USRDS, 2007). The longer a person has diabetes, the greater their risk of developing it.
Current understanding holds that controlling diabetes can help reduce the risk of developing kidney failure. However, many people with well-controlled diabetes still develop kidney disease and eventually kidney failure. High blood sugar levels cause damage to the kidneys, and the longer a person goes undiagnosed with diabetes, the more likely it is that damage has already occurred. A 20-year study by de Boer, Rue, and Hall et al. (2011) found that the incidence rate of diabetic kidney disease increased from 1988 to 2008, despite increased use of glucose-lowering medications and drugs designed to reduce other risk factors associated with the development of kidney disease (Koro, Lee, & Bowlin, 2009).
Newman, Mattock, and Dawnay et al. (2005) explored the effectiveness of early testing in detecting diabetic complications. They examined factors beyond microalbuminuria in diagnosing diabetic complications and investigated whether improved glycemic or blood pressure control had a greater influence on the development of complications in patients with detected microalbuminuria compared to those with normal albuminuria. This study found that glycemic control offered little benefit in preventing kidney disease in those who already had microalbuminuria. Those with normal albuminuria, however, appeared to benefit from glycemic control in terms of kidney disease prevention. The findings suggest that once the disease has begun, glycemic control does not significantly affect its ongoing progression, but that control prior to the onset of disease can help prevent it from developing. Separately, Watanabe, Fujii, and Aoki et al. (2009) found that obesity contributed to the development of kidney disease in patients with diabetes.
The literature presents conflicting information on the relationship between controlled diabetes and the development of kidney disease. Several other factors have been implicated, including high blood pressure and obesity, both of which may place individuals with diabetes at greater risk. Studies also suggest that once kidney disease has started, controlling blood sugar levels will not reverse its effects or slow its progression. The present study aims to help resolve some of these conflicting findings from prior research.
Conclusion
This study will examine the connection between diabetes and kidney disease in a detailed manner. The purpose of the study is to determine whether controlling diabetes affects the development or progression of kidney disease. The literature suggests that once a person develops kidney disease, controlling diabetes has little to no effect on its course. The presence of microalbuminuria will be used to classify patients who already have early-stage disease and to separate them from those who have not yet developed it. The study will play an important role in the prevention of kidney disease as a complication of diabetes.
References
de Boer, I., Rue, T., & Hall, Y., et al. (2009). Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA, 305(24), 2532–2539.
Koro, C., Lee, B., & Bowlin, S. (2009). Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States. Clinical Therapeutics, 31(11), 2608–2617.
Newman, D., Mattock, M., & Dawnay, A., et al. (2005). Systematic review on urine albumin testing for early detection of diabetic complications. Health Technology Assessment, 9(30), iii–vi, xiii–163.
United States Renal Data System. (2007). USRDS 2007 Annual Data Report. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, U.S. Department of Health and Human Services.
Watanabe, Y., Fujii, H., & Aoki, K., et al. (2009). A cross-sectional survey of chronic kidney disease and diabetic kidney disease in Japanese type 2 diabetic patients at four urban diabetes clinics. Internal Medicine, 48(6), 411–414.
Create your account
Always verify citation format against your institution’s current style guide requirements.